Wordt geladen...
Her-2/neu amplification and breast cancer survival: Results from the Shanghai breast cancer study
Her-2/neu is a member of the epidermal growth factor receptor family that has been found to be overexpressed or amplified in ~20-30% of breast cancers. Negative prognosticators and a shortened survival have been shown to be associated with these changes in Her-2/neu, but previous studies have consis...
Bewaard in:
| Gepubliceerd in: | Oncol Rep |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6519112/ https://ncbi.nlm.nih.gov/pubmed/18425397 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|